Fenix Innovation Group
Fenix Innovation Group
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NTI164 in Autism Spectrum Disorder | Chemically-Induced Disorders, autism, autism spectrum disorder, cannabis dependence, neurodevelopmental disorder, pervasive developmental disorder, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 3 | 2026-09-30 | NCT07257939 | |
| Efficacy and Safety of NTI164 in Children and Young Adults With Rett Syndrome | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Neurobehavioral Manifestations, Neurologic Manifestations, Rett syndrome, X-linked disease, cannabis dependence, hereditary disease, inherited neurodegenerative disorder, intellectual disability, nervous system disorder, psychiatric disorder, substance-related disorder | Not yet recruiting | Phase 2 / Phase 3 | 2026-09-09 | NCT07257978 |